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Abstract: The importance of chirality in drug development is unquestionable, with chiral liquid
chromatography (LC) being the most adequate technique for its analysis. Among the various types
of chiral stationary phases (CSPs) for LC, brush-type CSPs provide the base for interaction analysis
of CSPs and enantiomers, which provide valuable results that can be applied to interaction studies
of other CSP types. In order to analyze the influence of aromatic interactions in chiral recognition,
we designed a set of ten new brush-type CSPs based on (S)-N-(1-aryl-propyl)-3,5-dinitrobenzamides
which differ in the aromatic unit directly linked to the chiral center. Thirty diverse racemates,
including several nonsteroidal anti-inflammatory drugs and 3-hydroxybenzodiazepine drugs, were
used to evaluate the prepared CSPs. Chromatographic analysis showed that the three new CSPs
separate enantiomers of a wide range of compounds and their chromatographic behavior is
comparable to the most versatile brush-type CSP—Whelk-O1. The critical role of the nonbonding
interactions in positioning of the analyte (naproxen) in the cleft of CSP-6, as well as the analysis of
interactions that make enantioseparation possible, were elucidated using computational methods.
Furthermore, the influence of acetic acid as a mobile phase additive, on this enantiorecognition
process was corroborated by calculations.
Keywords: chiral chromatography; chiral recognition; intermolecular interactions; chiral drugs;
Whelk-O1 column; mobile phase additives
1. Introduction
Chirality is an essential property in the development of pharmaceutical drugs, as well as in
agrochemistry, food science, etc. It was put into the foreground in 1992 when the FDA issued
its policy statement concerning the development of stereoisomeric drugs [1]. Even though the
development of enantiopure compounds was not mandatory, it became the de facto standard in
the pharmaceutical industry, also enabling the new possibilities in drug development, i.e., the chiral
switch concept [2]. Accordingly, the need for fast, simple and reliable methods for separation of
enantiomers, determination of enantiomeric excess (ee) and absolute configuration (AC) has increased.
Although chiral liquid chromatography (chiral LC) has a great influence on the determination of
absolute configuration [3], its main role is being the most powerful method for the separation of
enantiomers [4] and for measuring the enantiopurity of organic compounds. Since the 1990s, when
the availability of chiral stationary phases (CSPs) became widespread, chiral LC using CSPs has been
the most widely used technique for chiral separations [5]. Besides being simple, versatile and reliable
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method, chiral LC has also became an ultrafast technique with enantioseparations in the sub-minute
time frame [6–12].
Over time, various types of CSPs have been developed, including more than a hundred which
have been commercialized. Their properties and mechanism of enantioseparation depend on the
nature of the chiral selector [5,13]. Polysaccharide-based CSPs are the most broadly applied for chiral
LC separations [14]. However, there are also several Pirkle-type (or brush-type) CSPs, e.g., Whelk-O1
and ULMO, whose versatility has enabled their wide application [13,15]. These CSPs, which consist
of small organic molecules covalently bound to the support, are also the most widely investigated
CSPs regarding the chiral recognition mechanism [13,16]. The understanding of chiral separation
mechanism is essential for estimating elution order, predicting the types of analytes which can be
separated on a certain CSP, and improving the design of new selectors. Clearly, the enantioseparation
process is easier to elucidate by analyzing interactions of the analyte and a small selector compared to
polysaccharide CSPs, whether using experimental or computational methods [5]. Chiral recognition of
brush-type CSPs is based on well-documented interactions between the selector and enantiomers of
the analyte—hydrogen bonds, dipole-dipole interactions, van der Waals interactions and, in particular,
aromatic interactions [16].
The goal of this research was threefold. First, ten new brush-type CSPs were prepared, with
a molecular design based on previous studies of chiral recognition in CSP [13,17–19]. The objective
was to obtain a CSP with a versatility as similar as possible to the Whelk-O1 column, the brush-type
CSP with the broadest application in industry and academia. We opted for a structure with one amide
bond, analogous to the Whelk-O1 column, and two aromatic groups—a 3,5-DNB aromatic unit and
a substituted aromatic moiety (Figure 1). We tested the prepared CSPs using thirty diverse racemates
and determined the CSPs with the best performance. Second, the variability of the aromatic moiety
enabled us to elucidate the influence of aromatic substituent on the enantiorecognition process. Keeping
that in mind, we investigated the role of nonbonding interactions relevant for chiral recognition on
CSPs using computational methods, with special attention to hydrogen bond networks and aromatic
interactions. Third, we explored the influence of acetic acid as an additive in the mobile phase using
extensive ab initio methods. To the best of our knowledge, this is the first study that examines
the possibility of positioning a minor additive within the chiral binding site and its influence on
enantiospecific interactions.
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2. Results and Discussion
2.1. Preparation of New Brush-Type Chiral Stationary Phases (CSPs)
We previously described the synthesis and determination of an absolute configuration of
(S)-N-(1-aryl-allyl)-3,5-dinitrobenzamides (DNB-1–DNB-10) [20]. These compounds are excellent
candidates for the preparation of a new Pirkle-type CSPs for HPLC since they possess all properties of
a good selector—they are rigid and contain a strong pi-acceptor acid (DNB) as well as a pi-donor base
aromatic group. Furthermore, allyl group in the structure of DNBs enables their binding to silica gel
using a simple and straightforward procedure.
For the binding of the chiral DNB selectors onto silica gel we chose a method that does not
introduce additional polar moieties into the CSP structure (Scheme 1) [21]. Hydrosilylation of DNBs
was conducted using chlorodimethylsilane and Speier’s catalyst, followed by the replacement of
a chloride with an ethoxy group using trimethylamine and ethanol. Obtained compounds were passed
through short silica column and attached to 5 µm silica gel in boiling toluene. Before the end-capping
procedure, we analyzed prepared CSPs using elemental analysis and infrared spectroscopy in order to
determine the amount of selector attached onto the silica gel. We performed end-capping in the last
step to protect free silanol groups with hexamethyldisilazane [22]. Ten new CSPs were thus prepared
from the corresponding DNBs (Figure 1) with the optimal 0.2 mmol selector per 1 g of CSP loading [21].
The as-prepared CSPs were finally packed in steel columns using the slurry packing technique.
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Scheme 1. Preparation of new brush-type chiral stationary phases (CSPs) from corresponding
(S)-N-(1-aryl-allyl)-3,5-dinitrobenzamides (DNBs).
2.2. Evaluation of Prepared CSPs
In order to test the performance of the prepared CSPs we used a diverse set of analytes (Figure 2)
which is usually used by our group to evaluate new CSPs [18,19]. The evaluation of prepared CSPs was
performed in normal phase chromatography mode using the mixtures of hexane and 2-propanol as
the mobile phase at room temperature and with UV detection at 254 nm. Compounds 1–7 and 9 were
analyzed in the mobile phase containing 10% of 2-propanol in hexane, while the obile phase for the
analysis of compounds 8 and 10–21 contained 20 of 2-propanol due to their longer retention times.
Our goal was to evaluate CSPs with respect to their difference in molecular structure and consequently
to neglect the influence of quality of the column packing, column dimensions, etc. Therefore the
relevant value for consideration is the separation factor (selectivity, α), which depends the most on the
structure of the CSP and has the greatest influence on overall resolution.
Tested set of compounds can be subdivided into four subsets. Compounds 1–4 are small molecules
with one or none carbonyl groups which could be the acceptor but not the donor of hydrogen bonds.
Because of these characteristics, the satisfactory enantioseparation of compounds 1–4 is usually
hard to achieve on brush-type CSPs. The second subset consists of compounds 5–9 which possess
bigger aromatic groups and hydroxyl or amino groups capable of hydrogen bond for ation. These
compounds are usually well separated on brush-type CSPs. Finally, there are two subsets consisting of
Molecules 2019, 24, 823 4 of 16
aromatic amides, 10–21, with the last subset (15–21) also bearing an ester group. These compounds
can form strong hydrogen bonds and aromatic interactions which makes them easier to separate using
brush-type CSPs.
Molecules 2019, 24, x FOR PEER REVIEW  4 of 15 
 
subsets consisting of aromatic amides, 10–21, with the last subset (15–21) also bearing an ester group. 
These compounds can form strong hydrogen bonds a d aromatic interactions which makes them 
easier to separate using brush-type CSPs. 
 
Figure 2. Structures of the racemic analytes used for the evaluation of prepared CSPs. 
The results indicate that CSPs which contain substituted phenyl aromatic groups, in most cases 
do not resolve compounds 1–4 (Figure 3). Enantioseparation of these compounds is better using the 
naphthyl series of CSPs, although the separation of compounds 3 and 4 is achieved on just a few 
CSPs. In general, enantioseparation results obtained for compounds 5–9 are better. Overall, the 
lowest separation factor is observed with CSPs like CSP-3, CSP-4 and CSP-5, which have more than 
one methyl substituent or methyl at the ortho position of the phenyl core.  
 
Figure 3. Separation factors of compounds 1–9 on prepared CSP-1–CSP-10, mobile phase hexane-2-
propanol = 90:10. For compound 8, the mobile phase ratio was 80:20. 
1 2 3 4 5 6 7 8 9 10
1.0
1.1
1.2
1.3
1.4
1.6
1.8
2.0
α
CSP
1
2
3
4
5
6
7
8
9
Figure 2. Structures of the racemic analytes used for the evaluation of prepared CSPs.
The results indicate that CSPs which contain substituted phenyl aromatic groups, in most cases
do not resolve compounds 1–4 (Figure 3). Enantioseparation of these compounds is better using the
naphthyl series of CSPs, although the separation of compounds 3 and 4 is achieved on just a few
CSPs. In general, enantioseparation results obtained for compounds 5–9 are better. Overall, the lowest
separation factor is observed with CSPs like CSP-3, CSP-4 and CSP-5, which have more than one
methyl substituent or methyl at the ortho position of the phenyl core.
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Figure 3. Separation factors of compounds 1–9 on prepared CSP-1–CSP-10, mobile phase
hexane-2-propanol = 90:10. For compound 8, the mobile phase ratio was 80:20.
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Compounds 10–14 are resolved well using all CSPs, with the only exceptions being CSP-3 and
CSP-5 (Figure 4a). These CSPs demonstrate the lowest separation factors due to their phenyl aromatic
group in the combination with two or three methyl substituents near the chiral carbon atom, which
disturb the enantiorecognition process due to steric hindrance. Also, the retention times of these
compounds are shorter for the phenyl series of CSPs than the naphthyl series (Table S2). This means
that interactions are weaker, as expected for smaller aromatic systems.
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Figure 4. Separation factors of compounds 10–14 (a) and 15–21 (b) on prepared CSP-1–CSP-10, mobile
phase hexane-2-pro a l 80:20.
The initial assu ption as that 3,5-dinitrobenzoyl derivatives of a ino acids ith an isopropyl
protecting group 15–21 ould be resolved ell on the prepared CSPs since they possess aromatic,
ester and a ide groups potentially capable of for ing interactions ith CSPs hich ay result in
chiral recognition. However, the difference between the phenyl series of CSPs and larger aro atic
substituents is even ore pronounced in these examples (Figure 4b). Here, it is demonstrated that only
CSPs with larger aromatic groups (naphthyl and phenantryl) show very good enantio-separations of
these compounds. The lowest results in the naphthyl series were obtained for CSP-8 which possesses
a methyl group at position 2 of the naphthyl ring.
It is interesting to point out that the enantioseparation of race ate 19 on the prepared CSPs is
quite unexpected (Figure 5). On the CSPs which show the overall lowest enantioseparation capabilities,
its separation factor is the highest in the 15–21 subset. On the contrary, on the CSPs that demonstrate
the best performance, this separation factor is the lowest of the subset. This result exemplifies how
chiral recognition is difficult to predict and often depends on subtle details.
The above presented results demonstrate that both size and substitution of aromatic group play an
important role in the enantioseparation capabilities of prepared CSP. Larger aromatic groups (naphthyl
and phenanthryl) overall display higher separation factors for the tested set of racemates. This is
expected since intermolecular aromatic interactions, which positively influence the chiral recognition,
are stronger for larger aromatic groups. Substitution of more than one methyl group on the phenyl
ring decreases the separation factor for all the tested racemates. On the other hand, the influence of
the monosubstitution of the aromatic group shows two opposite trends. When the substitution is at
the 4-position, there is no noticeable difference compared to the aromatic group without substituents
(CSP-1 compared to CSP-2 and CSP-6 to CSP-7). Contrarily, substitution at the 2-position greatly
influences the enantioseparation capabilities of the prepared CSPs (CSP-2 compared to CSP-4 and
CSP-7 to CSP-8). The methyl substituent in this case is near the chiral center and can influence the chiral
recognition in two ways—it sterically hinders the chiral center which decreases enantiorecognition and
it increases the rigidity of the CSPs by reducing the rotational freedom around C*-CAr bond (Figure 6).
The influence of the rigidity of CSP on enantioseparation capability is substantial. CSP-9 compared
to CSP-6 demonstrates higher flexibility and somewhat lower enantioseparation characteristics (see
Figures 3 and 4). On the other hand, CSP-8 compared to CSP-6 has higher rigidity and considerably
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decreased enantioseparation results (which are partially due to steric hindrance of the chiral center).
This indicates that a good CSP should be sufficiently rigid to strongly interact with one sterically
compatible enantiomer, but also flexible enough to accommodate the analyte and achieve a maximum
number of interactions for a wide range of compounds.
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Figure 5. Chromatogram of the separation of racemate 19 on CSP-10 (a) and CSP-8 (b); mobile phase
hexane-2-propanol = 80:20, flow 1mL/min, UV detection at 254 nm.
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Figure 6. Relaxed potential energy surface scan around C*-Cα bond of DNB-6 (red), DNB-8 (yellow)
and DNB-9 (blue). Dihedral angle Φ is defined by atoms Cβ-Cα-C*-N. Calculations were performed
on M06-2X/aug-cc-pVDZ level of theory.
2.3. Enantioseparation of Pharmaceutical Drugs on Prepared CSPs
Since CSPs bearing naphthyl and phenanthryl aromatic groups were demonstrated as more
versatile than phenyl CSPs, CSP-6–CSP-10 were chosen for testing the enantioseparation of
several pharmaceutical drugs including non-steroidal anti-inflammatory drugs (NSAIDs) and
3-hydroxy-benzodiazepine drugs (Figure 7).
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Figure 7. Structures of the tested non-steroidal anti-inflammatory drugs (NSAIDs) and 3-hydroxy-
benzodiazepine drugs.
Given that NSAIDs are organic acids, acetic acid (0.1%) was selected as the mobile phase additive.
Acidic additives are frequently used in the mobile phases for the analysis of acidic analytes because of
their positive influence on the peak shape and retention time [23]. Results of the enantioseparation of
NSAIDs on the prepared CSP-6–CSP-10 (Figure 8a) showed that only naproxen is resolved well on
prepared CSPs, while some of the drugs from our test set are only partially resolved on CSP-7.
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It as de onstrated that in so e cases neutral salts, uch as a o iu ac tate or a o iu
for ate, have a positive fluence on the enantioseparation of race ates [23]. For xa ple, S I s
sho ed excellent enantioseparation results on lk- 1 colu ns using a obile phase ith
a oniu acetate as an additive [24]. Therefore, e investigated the enantioseparation perfor ance
of the ne ly prepared SP-6– SP-10 on S I s also using a oniu acetate as a obile phase
additive (Figure 8a). lthough SP-8 and SP-9 still only separate the enanti ers of naproxen, the
perfor ance of the re aining SPs as subst ntially i proved. This is especially evident in the case
of CSP-10 (Figure 9) which can separate all of the tested NSAIDs using the abovementioned conditions.
Compounds 8 and 9, which are structural analogs of 3-hydroxybenzodiazepines with an ester
group at the 3-position, were resolved well using the prepared CSPs. Therefore, we decided to test
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the naphthyl series of CSPs for the enantioseparation of 3-hydroxybenzodiazepine drugs (Figure 8b).
Since these compounds possess acidic and basic groups, ammonium acetate was also used as a mobile
phase additive. 3-Hydroxybenzodiazepine drugs show very good enantioseparation results on the
prepared CSPs, with the best results obtained on CSP-6, CSP-7 and CSP-10.
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veral , the best separation factors for the nantiosepar tion of the t s d drugs were obtained on
CSP-6, CSP-7 and CSP-10. Given the importance of these compounds in the pharmaceutical ind stry,
their enan iosepar tion was previously analyzed on several comm cial brush-type CSP, including
Whelk-O1 [24]. In order to compa e the results obtained on ur CSP with the results obtained for
Whelk-O1, we analyzed th se pharmaceutical d ugs using the same hexan —2-propanol = 80:20 + 1 g
dm−3 NH4OAc mobile phase (Table 1).
Table 1. Comparison of the separation factors (α) of teste ar ce tic l r s t i - ,
SP-7, CSP-10 and helk-O1 1.
Compound Whelk-O1 CSP-6 CSP-7 CSP-10
Ibuprofen 1.71 1.00 1.50 1.19
Ketoprofen 1.30 1.10 1.20 1.12
Naproxen 1.48 1.82 2.39 2.14
Flurbiprofen 1.68 1.14 1.53 1.27
Suprofen 1.27 1.11 1.16 1.11
Fenoprofen 1.60 1.26 1.55 1.24
Lorazepam 2.29 1.93 2.54 2.48
Oxazepam 1.97 1.39 1.59 1.59
Temazepam 1.38 1.31 1.39 1.45
1 For the analyses (S,S)-Whelk-O1 column (5 µm particle size, 250 × 4.6 mm I.D.) was used.
From the obtained results it is evident that these three new CSPs have promising enatioseparation
capabilities which are comparable to those of Whelk-O1. Furthermore, it must be emphasized that
the column Whelk-O1, being a commercial one, is technologically optimized regarding the choice of
silica gel used as the support, the binding procedure, as well as the packing procedure. It is known
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that all of these conditions influence the enantioseparation capabilities of CSPs [25,26]. The prepared
CSPs haven’t been optimized at this point, leaving plenty of room for improvement of these CSPs.
These columns have one more advantage over Whelk-O1. In order to prepare Whelk-O1 enantiopure
selector, preparative chiral chromatography must be used which has low productivity due to the low
solubility of the compound [27,28]. On the other hand, the enantiopure selectors of our CSPs (DNB-6,
DNB-7 and DNB-10) can be obtained by enzyme resolution using a cheap commercial lipase—Candida
antarctica lipase B (CAL-B) [20,29].
2.4. Analysis of Interactions Responsible for Chiral Recognition between Naproxen and CSP-6
To explore the nature of chiral binding site, a set of molecular dynamics simulations in vacuum of
CSP-6 with naproxen was performed. Since we are interested in distinguishing the details that enable
enantiomeric separation, simulations were run separately for (S)- and (R)-enantiomers of naproxen.
According to a 1H-NMR study of chiral recognition of (S)- and (R)-naproxen in the presence of
Whelk-O1 selector analog [30] and to the molecular dynamics simulations of the interface of modified
Whelk-O1 selector and naproxen in n-hexane [31], both enantiomers of naproxen dock inside the cleft,
most probably by an M1 mechanism [32,33]. The main feature of the M1 mechanism is a hydrogen
bond between the drug and the amide hydrogen, while aromatic interactions with the dinitrophenyl
moiety introduce additional stability to the complex. For simplicity in our computational models
we have neglected the non-polar solvent and a linker, the interface to silica gel, substituting it with
a hydrogen atom.
The complex of CSP-6 and (S)-naproxen ((S)-A) has lower energy (by 1.8 kcal mol−1) than the
lowest energy complex of CSP-6 and (R)-naproxen ((R)-A) (Figure 10). This result is in accordance
with the experimental results which demonstrate that (R)-naproxen is the first eluting enantiomer
on CSP-6 (Figure S1). Ten additional complexes within 2.9 kcal mol−1 were examined (Figure S2).
In (S)-A complex the naphthyl and DNB subunits are almost perpendicular to each other. Naproxen
is hydrogen bonded to the amide hydrogen (2.00 Å), with the carbonyl oxygen being a H-bond
acceptor and in the vicinity of the β-hydrogen of DNB, being only 2.44 Å apart. The second most
important H-bridge is between an oxygen of the DNB nitro group and the hydrogen from the naproxen
carboxyl group. The weakest interaction of this type is responsible for anchoring the opposite side of
naproxen, the methoxy moiety, to the second nitro group of the DNB subunit. The parallel face-centered
stacking arrangement between the two aromatic rings with the distance between the centroids of
the naproxen and DNB rings of 4.11 Å, represents a good example of aromatic interaction between
strongly electron-deficient (DNB) and neutral aromatic rings (Figure 10b). The next intriguing space
oriented interaction is the H-aromatic interaction [34], where three hydrogens of naproxen, including
the hydrogen on the chiral carbon atom, are oriented toward the naphthyl ring, forming a recognizable
T-shaped motif whose rings’ planes form an angle of 75◦. Alternative modes of complexation are
also found, like the one where naproxen is outside the cleft ((S)-A-4) or a complex where naproxen
is hydrogen bonded to the carbonyl oxygen of CSP-6 ((S)-A-5). Those complexes are 2.5 kcal mol−1
higher in energy than (S)-A, and will not be discussed further.
Just by reversing groups at the chiral carbon on naproxen in the (S)-A complex and running
optimization, a new complex is identified, (R)-A-2, 2.8 kcal mol−1 higher in energy (see Supplementary
Materials). The O-H···O bond is shorter by 0.10 Å, while O···H-N is 0.03 Å longer than the analogous
bonds in (S)-A, but the orientation of the methyl group toward the naphthyl part of CSP-6 perturbs the
parallel face-centered stacking arrangement almost perfectly possible in the (S)-enantiomeric complex.
The H-aromatic interaction network is also perturbed, which can be seen from the fact that only
hydrogens from the α ring are pointing toward naphthyl moiety.
The (R)-A complex, more stable than (R)-A-2 by 0.9 kcal mol−1, is characterized by even stronger
hydrogen bonds between the naproxen carboxyl group and DNB (1.86 Å) and the amide hydrogen
(1.99 Å). The anchoring interaction between the methoxy hydrogen and the nitro group is missing,
which is reflected in the increased distance between the centroids of an aromatic ring of naproxen and
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the DNB subunit to 5.29 Å. By comparing the (R)-A and (R)-A-2 structures it is possible to conclude that
the main contribution to the stabilization of the complexes comes from hydrogen bonding with aromatic
and H-aromatic interactions playing a minor, but significant role in the enantiorecognition process.
Our findings are in agreement with similar theoretical studies on the chiral recognition of
Whelk-O1. For a series of complexes of naproxen with Whelk-O1 and modified CSPs, the M1
mechanism is identified as the most probable docking mechanism [31]. Furthermore, the formation of
the hydrogen bond was found to be critical for the successful separation of enantiomers [35].
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2.5. Influence of Acetic Acid as the Mobile Phase Additive on The Enantioseparation of Naproxen on CSP-6
Although it is empirically known that minor additives (organic acids, bases or neutral salts)
may have positive effect on the shape of peaks, retention times and selectivity [23], experimental
studies on the mechanism of how additives influence enantioseparation are scarce. Several
systematic experimental studies were performed, mostly on polysaccharide CSPs under normal phase
conditions [36–38], as well as using polar organic mobile phases [38–40]. Generally, the consensus is
that additives in the mobile phase improve the solubility of acidic analytes in nonpolar solvents and
suppress non-chiral interactions of analyte with the CSP surface (masking effect), and therefore reduce
tailing and can increase selectivity. However, an explanation for the way in which additives could
affect the chiral recognition process between the analyte and CSP remains elusive. Some studies [36,39]
hypothesize that additives have an ability to displace the analyte or to influence the selector-analyte
complex by interfering with the interactions that stabilize the complex, however, these speculative
explanations of experimental results have not been substantiated so far.
Our goal was to investigate the possibility of influence of additives on intermolecular interactions
between analyte and CSP during enantiorecognition. We opted for acetic acid, a simple acidic additive,
and a system we had already investigated—naproxen and CSP-6. Acetic acid is known to form dimers
in the gas phase and in nonpolar solvents characterized by a strong double hydrogen bond [41,42].
Since naproxen primarily interacts via its carboxylic group with CSPs, we explored the possibility of
an interplay of naproxen, acetic acid and CSP-6.
The most stabile complex of naproxen, acetic acid and CSP-6 is (S)-B, which is 3.9 kcal mol−1
lower in energy than (R)-B (Figure 11). A common motif of both structures is an 8-membered ring
formed by a double hydrogen bridge connecting acetic acid and the carboxylic acid group of naproxen.
In the (S)-B complex, the N-H···O bond length is 2.90 Å, while naproxen’s carbonyl oxygen serves as
a double H-bond acceptor, associating with acetic acid as well. The analogous bridge to (R)-naproxen
in (R)-B is longer (3.14 Å) and of a different nature – the H-acceptor is a carboxylic acid oxygen, which
is simultaneously an H-donor to acetic acid. Although acetic acid is not connected to naproxen via
enantioselective interactions, it modifies H-bond network compared to a complex without the acid
((S)-A and (R)-A). Firstly, the interaction between the carboxylate hydrogen and the nitro group is
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missing. Secondly, the methyl group of acetic acid is a weak H-donor to the nitro subunit. For (R)-B,
the presence of additive makes the contact between naproxen and CSP-6 along the carboxyl oxygen
more favorable.Molecules 2019, 24, x FOR PEER REVIEW  11 of 15 
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co plexes of naproxen and SPs, ith and ithout acetic acid, indicate that higher selectivity is
possible due to interactio s f acetic a iti e it t e l te .
3. Materials and Methods
3.1. General Information
All the solvents were puriss. p.a. or HPLC grade and were used directly as supplied by
Sigma-Aldrich Chemie GmbH (Munich, Germany), Alfa Aesar (Karlsruhe, Germany) or Acros (part of
Thermo Fisher Scientific, Geel, Belgium). For the preparation of chiral stationary phases HPLC silica
gel Separon SGX particle size 5 µm and pore size 80 Å from Tessek Ltd. (Prague, Czech Republic)
was used. IR spectra were recorded on an MB102 instrument (ABB Bomem, Zurich, Switzerland).
Elemental analyses were done on a 2400 CHNS Elemental Analyzer (Perkin-Elmer, Waltham, MA,
USA). Chiral HPLC analysis were performed using a Prominence System (Pump LC-20AT, DGU-20A5
Degasser, UV detector SPD-20A, Shimadzu, Kyoto, Japan) or a Knauer system (Pump Knauer 64,
4-Port Knauer Degasser, UV detector Knauer Variable Wavelength Monitor, Interface Knauer, Knauer,
Berlin, Germany, and a CD-2095 detector, Jasco, Easton, MD, USA). The packing of prepared CSP into
stainless steel columns (150 × 4.6 mm I.D.) was achieved using Knauer Pneumatic HPLC Pump. The
(S,S)-Whelk-O1 column, Regis Technologies, Inc. (Morton Grove, IL, USA), was 5 µm particle size and
had dimensions of 250 × 4.6 mm I.D.
Racemates 8–21 used for the evaluation of prepared columns were previously synthesized in
the Laboratory for Stereoselective Catalysis and Biocatalysis at the Ruđer Boškovic´ Institute [18,19].
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All other compounds were purchased from commercial sources and used without further purification.
Unless otherwise noted, the analyses of abovementioned racemates were performed at room
temperature using the flow of 1 mL/min and UV detection of the compounds at 254 nm.
3.2. General Procedure for the Preparation of CSP-OHs
The corresponding DNB amide (0.75 mmol) was suspended in dry DCM (10 mL) under an inert
atmosphere. A solution of hexachloroplatinic(IV) acid hydrate (20 mg) in isopropanol (0.5 mL) was
added to the reaction mixture, followed by chlorodimethylsilane (10 mL). The mixture was refluxed
for 5 h, cooled to room temperature and concentrated under reduced pressure. Dark residue was
once again dissolved in DCM (5 mL), concentrated under reduced pressure and used without further
purification. To the solution of the crude product in dry DCM (8 mL) under inert atmosphere, the 1:1
mixture of triethylamine and absolute ethanol (10 mL) was added dropwise and stirred at room
temperature for half an hour. The solvent was evaporated to give a dark residue which was filtered
through a short column of silica gel (eluent DCM-MeOH = 100:1). The resulting yellow residue was
dissolved in dry toluene (5 mL) and added to a suspension of 5 µm HPLC silica gel (1.50 g) in dry
toluene (50 mL). The silica gel was dried prior use for 24 h in Dean-Stark apparatus. The suspension
was refluxed for 24 h, then filtered using a G4 sinter and washed with toluene (30 mL) and methanol
(2 × 30 mL). Prepared CSP-OHs were dried for 4 h at 60 ◦C and elemental analysis results and IR
spectra were recorded.
CSP-1-OH CHN analysis: C 5.05; H 0.63; N 1.11 (0.23 mmol/1 g); IR (ν/cm−1): 3442 (SiO2), 1642,
1540, 1343, 1220–1031 (SiO2), 807 (SiO2), 465 (SiO2).
CSP-2-OH CHN analysis: C 4.20; H 0.85; N 0.62 (0.18 mmol/1 g); IR (ν/cm−1): 3450 (SiO2), 1641,
1544, 1346, 1219–1034 (SiO2), 807 (SiO2), 731, 466 (SiO2).
CSP-3-OH CHN analysis: C 4.91; H 0.93; N 0.75 (0.20 mmol/1 g); IR (ν/cm−1): 3434 (SiO2), 1640,
1539, 1219–1034 (SiO2), 808 (SiO2), 464 (SiO2).
CSP-4-OH CHN analysis: C 5.39; H 0.82; N 0.51 (0.24 mmol/1 g); IR (ν/cm−1): 3439 (SiO2), 1640,
1542, 1349, 1227–1030 (SiO2), 808 (SiO2), 731, 465 (SiO2).
CSP-5-OH CHN analysis: C 5.43; H 0.80; N 0.70 (0.22 mmol/1 g); IR (ν/cm−1): 3445 (SiO2), 1638,
1540, 1214–1029 (SiO2), 806 (SiO2), 467 (SiO2).
CSP-6-OH CHN analysis: C 5.45; H 0.55; N 0.77 (0.21 mmol/1 g); IR (ν/cm−1): 3448 (SiO2), 1645,
1543, 1347, 1217–1034 (SiO2), 805 (SiO2), 729, 465 (SiO2).
CSP-7-OH CHN analysis: C 6.13; H 1.15; N 1.10 (0.22 mmol/1 g); IR (ν/cm−1): 3452 (SiO2), 1643,
1545, 1346, 1235–1023 (SiO2), 805 (SiO2), 731, 460 (SiO2).
CSP-8-OH CHN analysis: C 6.73; H 1.17; N 0.41 (0.24 mmol/1 g); IR (ν/cm−1): 3469 (SiO2), 1638,
1545, 1348, 1230–1034 (SiO2), 807 (SiO2), 731, 463 (SiO2).
CSP-9-OH CHN analysis: C 5.36; H 0.63; N 0.96 (0.20 mmol/1 g); IR (ν/cm−1): 3451 (SiO2), 1636,
1544, 1350, 1228–1036 (SiO2), 807 (SiO2), 730, 468 (SiO2).
CSP-10-OH CHN analysis: C 6.41; H 1.07; N 1.06 (0.21 mmol/1 g); IR (ν/cm−1): 3439 (SiO2), 1630,
1542, 1347, 1223–1029 (SiO2), 806 (SiO2), 728, 464 (SiO2).
3.3. End-Capping and Packing Procedure
To a yellow suspension of prepared CSP-OHs in dry toluene (20 mL) in an inert atmosphere,
hexamethyldisilazane (2 mL) was added and resulting mixture was refluxed for 20 h. The suspension
was cooled, filtered using a G4 sinter and washed with toluene (30 mL) and methanol (2 × 30 mL).
After drying of prepared CSP overnight at 60 ◦C, they were packed into stainless steel columns
(150 × 4.6 mm I.D.) using the slurry packing technique (1.5 g of CSP was suspended in 25 mL of
solvent hexane-2-propanol = 2:8).
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3.4. Computational Methods
Minimum energy structures of DNB-6, DNB-8 and DNB-9 are taken from our previous
publication [20]. Relaxed potential energy surface scan was performed in Gaussian 16 [43] with
Minnesota global hybrid functional M06-2X [44] with 54% of the exact exchange and aug-cc-pVDZ
functional. The ethenyl moiety of (S)-DNB-6 from our previous work [20] was replaced by hydrogen.
Ground state force field parameters of CSP-6, naproxen and acetic acid were evaluated using the
antechamber module of the Amber 16 package and the generalized Amber force field (GAFF) [45]. After
geometry optimization of the complex of (S)-DNB-6 and naproxen (A) and (S)-DNB-6, naproxen and
acetic acid (B), molecular dynamics simulations at 300 K in vacuum were run, with a time step of
1 fs and a time simulation of 10 ns, for both the (S)- and (R)-enantiomers of naproxen. Geometries
were saved every 5 ps. The 20 lowest energy structures from the trajectories were optimized at
the B3LYP/def-SVP level of theory. The 10 most stable complexes were then re-optimized using
the same functional and larger basis set (def2-TZVPP), while final energies were evaluated on
M06-2X/def2-TZVPP level with solvation effects incorporated via COSMO model [46] and dielectric
constant that equals to 2.78. Geometry optimizations and single point energy calculations were run in
Turbomole [47].
4. Conclusions
In conclusion, we prepared ten new Pirkle-type chiral stationary phases based on
(S)-N-(1-aryl-propyl)-3,5-dinitrobenzamide selectors. We evaluated the prepared CSPs using thirty
diverse racemates, including several nonsteroidal anti-inflammatory and 3-hydroxybenzodiazepine
drugs. Our aim was to design CSPs with similar versatility to Whelk-O1 and three of our CSPs (CSP-6,
CSP-7 and CSP-10) indeed displayed chromatographic behavior comparable to this widely used CSP.
The prepared CSPs differ in the aromatic unit directly linked to the chiral center, which enabled us to
elucidate the influence of the size and substitution of aromatic moiety on the enantiorecognition
process. In order to substantiate experimental results, we investigated the role of nonbonding
interactions relevant for chiral recognition on CSPs using computational methods. The model system
was enantioseparation of naproxen on CSP-6 where we elucidated the influence of hydrogen bond
network and aromatic interactions on enantiorecognition process. Furthermore, the stability of the
complexes is in accordance with the experimentally determined elution order. Finally, we investigated
the influence of acetic acid as an additive in the mobile phase in the abovementioned system. To the
best of our knowledge, this study is the first one to investigate the possibility of positioning a minor
additive within the chiral binding site. We showed that non-enantiospecific interactions with the
carboxylic moiety of the analyte can change the interaction arrangements and influence the energetics
of the complexes responsible for chiral recognition.
Supplementary Materials: The Supplementary Materials are available online. Table S1: Enantioseparation
results of racemates 1–7 and 9 on CSP-1–CSP-10, Table S2: Enantioseparation results of racemates 8
and 10–14 on CSP-1–CSP-10, Table S3: Enantioseparation results of racemates 15–21 on CSP-1–CSP-10,
Table S4: Enantioseparation results of NSAIDs on CSP-6–CSP-10, Table S5: Enantioseparation results of
3-hydroxy-benzodiazepine drugs on CSP-6–CSP-10, Figure S1: Enantioseparation of naproxen on CSP-6, Figure
S2: Higher energy structures of (S)-A and (R)-A, Figure S3: Higher energy structures of (S)-B and (R)-B.
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